Patient-controlled analgesia (PCA) with codeine for postoperative pain relief in ten extensive metabolisers and one poor metaboliser of dextromethorphan

Br J Clin Pharmacol. 1995 Feb;39(2):182-6. doi: 10.1111/j.1365-2125.1995.tb04428.x.

Abstract

Postoperative pain relief with codeine was evaluated in 11 women undergoing hysterectomy. Patient-controlled analgesia (PCA) was used to administer codeine. After the study the patients were phenotyped with respect to the O-demethylation of dextromethorphan (cytochrome P4502D6 polymorphism). Ten were extensive metabolisers and one a poor metaboliser. There was a nine-fold variation in the minimum plasma concentration of codeine consistent with pain relief (40-350 ng ml-1). Two patients did not experience any effect of codeine, one of whom was a poor metaboliser of dextromethorphan, confirmed by genotyping. In the other nine patients the effective dose of codeine varied from 4.8-25.3 mg h-1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Analgesia, Patient-Controlled / methods*
  • Codeine / administration & dosage
  • Codeine / pharmacokinetics
  • Codeine / therapeutic use*
  • Cytochrome P-450 CYP2D6
  • Cytochrome P-450 Enzyme System / genetics*
  • Dextromethorphan / metabolism
  • Female
  • Genotype
  • Humans
  • Middle Aged
  • Mixed Function Oxygenases / genetics*
  • Pain, Postoperative / drug therapy*
  • Phenotype

Substances

  • Dextromethorphan
  • Cytochrome P-450 Enzyme System
  • Mixed Function Oxygenases
  • Cytochrome P-450 CYP2D6
  • Codeine